Yuebo Jin

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

Jing He, Xia Zhang, Yunbo Wei et al. · Nature Medicine · 2016 · 545 citations

Inflammation, Allergy, Systemic Lupus Erythematosus +12

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

Jing He, Ruijun Zhang, Miao Shao et al. · Annals of the Rheumatic Diseases · 2019 · 317 citations · Full text

Dietary intake and risk of rheumatoid arthritis—a cross section multicenter study

Jing He, Yu Wang, Min Feng et al. · Clinical Rheumatology · 2016 · 70 citations · Full text

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome

Jing He, Jiali Chen, Miao Miao et al. · JAMA Network Open · 2022 · 69 citations · Full text

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial

Xiaoying Zhang, Miao Miao, Ruijun Zhang et al. · Signal Transduction and Targeted Therapy · 2022 · 63 citations · Full text